Back to search

Peptide record

TPDB22365

Antibacterial Anticancer Hemolysis Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB22365
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0 PD_Hemolysis
standard
No
A 18-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from Peptipedia, CancerPPD 2.0, and PD_Hemolysis, with an available 3D structural model.
Sequence
KSCFRVCYRGICYRRCRG
Physicochemical Analysis
C93H152N34O22S4
ANDEQHLMPTW
R
2226.68
10.10
6
0
5
+6
0.98
-0.506
37.78
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
3230
145.06
7
Residue Composition
number
0
A
5
R
0
N
0
D
4
C
0
E
0
Q
2
G
0
H
1
I
0
L
1
K
0
M
1
F
0
P
1
S
0
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 5 N: 0 D: 0 C: 4 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 0 K: 1 M: 0 F: 1 P: 0 S: 1 T: 0 W: 0 Y: 2 V: 1
Chemical Descriptors
18
C93H152N34O22S4
2226.68
10.10
+6
0.98
-0.506
Evidence Records 5 records
Evidence 1 Activity

Activity

Hemolysis
Human RBCs: CC50>32 µM

Target

Human RBCs

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
ACS Chem Biol. 2019 Dec 20 14(12):2895-2908.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

50% Cell death
Toxicity
41.4±2.6 µM
Cytotoxic
50% Cell death | 41.4±2.6 | µM | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties. | ACS Chem Biol | 2019
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
>32 µM
Hemolytic Cytotoxic
50% Hemolysis | >32 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties. | ACS Chem Biol | 2019
Evidence 4 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Human RBCs: CC50>32 µM | Cytotoxicity: HaCaT: CC50=41.4±2.6 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
ACS Chem Biol. 2019 Dec 20 14(12):2895-2908.
Evidence 5 Hemolysis

Activity

Human RBCs: CC50>32 µM
Hemolysis

Target

Human RBCs

Source & Reference

PD_Hemolysis
ACS Chem Biol. 2019 Dec 20 14(12):2895-2908.
DRAMP4
PD_Hemolysis